Owens & Minor Inc is primarily active in the healthcare industry.

The main competitors of Owens & Minor Inc in the market include McKesson Corporation, Cardinal Health Inc, and Medline Industries Inc.

Owens & Minor Inc is a renowned healthcare logistics company with a rich history and background. Established in 1882 in Richmond, Virginia, the company has evolved into a trusted provider of global healthcare solutions. Through strategic acquisitions and organic growth, Owens & Minor has expanded its services to encompass distribution, third-party logistics, and technology solutions for hospitals and healthcare systems worldwide. With a strong commitment to delivering high-quality products and excellent customer service, Owens & Minor continues to revolutionize the healthcare supply chain. As a result, the company has gained a reputation for reliability, efficiency, and innovation in the healthcare industry.

Owens & Minor Inc. has achieved several significant milestones. In 2020, the company celebrated its 135th anniversary, reflecting its long-standing presence in the healthcare industry. They have expanded their global reach by acquiring ArcRoyal, a leading medical and surgical supply distributor in Canada. Owens & Minor Inc. also achieved recognition as one of America's Most Responsible Companies by Newsweek. With a focus on innovation, they launched the O&M Surgical Efficiency Program to enhance patient care and reduce costs. These milestones highlight Owens & Minor Inc.'s commitment to delivering exceptional healthcare solutions and driving positive change within the industry.

Owens & Minor Inc is primarily present in the United States.

Owens & Minor Inc is a stock that represents strong values and corporate philosophy. The company is committed to delivering quality healthcare products and services to its customers. Owens & Minor Inc places a great emphasis on integrity, transparency, and ethical behavior in its operations. The company strives to maintain strong relationships with its customers, suppliers, and employees, fostering a culture of collaboration and respect. Owens & Minor Inc also prioritizes innovation and continuous improvement, constantly seeking new ways to enhance healthcare delivery. With its customer-centric focus and dedication to excellence, Owens & Minor Inc is a trusted name in the industry.

Analysts currently set an average price target of 3.77 USD for the Accendra Health stock (median: 4.08 USD), implying +22.1 % versus the latest price. The consensus is based on 12 analyst ratings.

Accendra Health Analyst Price Targets 2026

12 analysts currently rate the Accendra Health stock: 1 recommend buying, 4 holding and 7 selling. For 2026, analysts expect Accendra Health to generate revenue of 2.58 B USD and earnings per share of 0.41 USD.

Accendra Health Analyst Price Targets 2026

Converted at the current exchange rate, the Accendra Health share trades at 2.68 EUR (3.09 USD).

The Accendra Health share (ACH) is listed on 5 stock exchanges, including: NYSE (OMI), NASDAQ (OMI), Frankfurt (6OM.F), München (6OM.MU), Düsseldorf (6OM.DU).

Owens & Minor Inc. is a globally operating company that specializes in providing medical equipment, consumables, and services to healthcare facilities. The company was founded in 1882 and has always strived to offer its customers the best possible service. Owens & Minor Inc.'s business model primarily revolves around supplying medical consumables and equipment to clinics, hospitals, and healthcare facilities worldwide. The company also collaborates with manufacturers of medical accessories and supplements their offerings with their own products, allowing them to provide a wide range of medical supplies to their customers. The company's core divisions include Global Solutions, which focuses on global procurement and logistics of medical consumables and equipment, ensuring that customers always have sufficient stock to meet their needs. Global Solutions also offers training to ensure proper product usage. Another important division is Global Products, where medical products are manufactured and distributed that are not offered by other manufacturers. This includes specialized catheters, casting and bandaging materials, as well as infusion therapy products, marketed under the brand name 'Medichoice'. In addition to these core divisions, Owens & Minor Inc. offers a variety of services, including assisting customers with the implementation of new medical devices and procedures, ensuring compliance with regulations, and providing tailored consulting services. The company has also pursued strategic acquisitions to expand and diversify its business. For example, in 2018, it acquired Byram Healthcare, a company specializing in home patient care, allowing Owens & Minor Inc. to establish a presence in this area as well. In summary, Owens & Minor Inc.'s business model focuses on providing healthcare customers with medical consumables, equipment, and services. Through collaboration with manufacturers, in-house production of medical accessories, and global procurement and logistics, the company is able to offer a wide range of products to its customers. Additionally, it supports customers with the implementation of new procedures, compliance with regulations, and consulting services to ensure optimal care.

The expected revenue of Accendra Health is 2.58 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Accendra Health is 31.53 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Accendra Health is currently 7.52. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Accendra Health stock.

The price-to-sales ratio (P/S) of Accendra Health is currently 0.09. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Accendra Health stock.

The Eulerpool Quality Score for Accendra Health is 2/10.

The ISIN of Accendra Health is US6907321029. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Accendra Health is 904611. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Accendra Health is ACH. The ticker symbol is used to trade Accendra Health shares on the stock exchange.

Over the past 12 months, Accendra Health paid a dividend of 0.01 USD . This corresponds to a dividend yield of about 0.32 %. For the coming 12 months, Accendra Health is expected to pay a dividend of 0.01 USD.

The current dividend yield of Accendra Health is 0.32 %.

Accendra Health pays a dividend, distributed in the months of , , , .

Accendra Health paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 0.01 USD are expected. This corresponds to a dividend yield of 0.32 %.

Accendra Health is assigned to the 'Health' sector.

To receive the latest dividend of Accendra Health from amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Accendra Health are distributed in USD.